4.1 ABO & Rh Blood Group Systems

ABO Blood Group System

The ABO blood group system is the most critical in transfusion medicine due to the predictable presence of naturally occurring antibodies (isoagglutinins) against the antigens absent on an individual's red blood cells (RBCs). These antibodies are typically of the IgM class, react at room temperature, and can cause severe, life-threatening acute hemolytic transfusion reactions if incompatible blood is transfused. The predictable nature of these antibodies, described by Landsteiner's rule, dictates that a person possesses the antibody against the ABO antigen they lack. This rule is the absolute foundation of all safe blood transfusion practices.

Biochemistry and Immunodominant Sugars

The ABO antigens are carbohydrate structures attached to precursor chains (glycosphingolipids or glycoproteins) on the RBC membrane. The specificity of the A and B antigens is determined by the terminal sugar added to the H antigen precursor. The H gene (FUT1) codes for an enzyme, alpha-2-L-fucosyltransferase, which adds L-fucose to the terminal galactose of the Type 2 precursor chain. This forms the H antigen, which is the necessary foundation for the A and B antigens. If an individual lacks the H gene (genotype hh), they cannot form the H antigen, resulting in the rare Bombay phenotype, which types as O but will produce strong anti-H and cause severe reactions if transfused with normal group O blood.

Once the H antigen is formed, the A and B genes code for specific glycosyltransferases that add the final, immunodominant sugars:

• Blood Group A: The A gene codes for alpha-3-N-acetylgalactosaminyltransferase, which adds N-acetylgalactosamine to the H antigen. Group A is further subdivided into A1 (approx 80%) and A2 (approx 20%). A1 individuals have more antigen sites and a more complex branching structure. A2 individuals can sometimes form naturally occurring anti-A1 antibodies, which can cause ABO discrepancies in reverse typing.
• Blood Group B: The B gene codes for alpha-3-D-galactosyltransferase, which adds D-galactose to the H antigen.
• Blood Group O: The O gene is an amorph; it produces no active enzyme. Therefore, group O cells have an abundance of unconverted H antigen (and no A or B antigens). Because they have the most H antigen, group O cells are used as screening cells for unexpected alloantibodies.
• Blood Group AB: Both enzymes are present, adding both N-acetylgalactosamine and D-galactose to the H antigen precursors.

ABO Discrepancies

An ABO discrepancy occurs when the forward and reverse typing results do not align. All discrepancies must be investigated and resolved before a final blood type can be assigned and blood products issued.

Discrepancies are categorized into four main groups:

• Group I Discrepancies (Antibody Problems): The most common type, typically caused by missing or weak antibodies in the reverse typing. Common in newborns, the elderly, immunocompromised patients, or those with hypogammaglobulinemia. Resolution involves incubating the reverse typing tubes at room temperature for 15-30 minutes, or at 4°C (with autologous and O cell controls to rule out cold autoantibodies).
• Group II Discrepancies (Antigen Problems): Caused by missing or weak antigens in the forward typing. Examples include subgroups of A (e.g., A2, A3) or B, leukemia (altered antigen expression), or the "acquired B" phenomenon (associated with colon cancer or Gram-negative sepsis, where bacterial enzymes alter the A antigen to resemble the B antigen). Resolution involves incubating forward typing at room temperature or 4°C, or using anti-A1 lectin (Dolichos biflorus) to differentiate A1 from A2.
• Group III Discrepancies (Protein Problems): Caused by protein or plasma abnormalities resulting in rouleaux (coin-like stacking of RBCs), which mimics agglutination. Common in multiple myeloma, Waldenström's macroglobulinemia, or elevated fibrinogen. Resolution involves saline replacement in the reverse typing.
• Group IV Discrepancies (Miscellaneous): Include cold autoantibodies, polyagglutination, or unexpected alloantibodies in the reverse typing.

Rh Blood Group System

The Rh system is highly immunogenic, meaning exposure to an antigen an individual lacks is very likely to stimulate the production of an alloantibody (typically IgG). Unlike the ABO system, Rh antibodies are not naturally occurring; they require immune stimulation through transfusion or pregnancy.

Rh Genetics and Terminology Conversions

Two primary nomenclatures describe the Rh system:

1. Fisher-Race (CDE) Terminology: Postulated three closely linked sets of alleles (D/d, C/c, E/e). The 'd' allele is theoretical (absence of D). Haplotypes are written as sets of three (e.g., DCe, dce).
2. Wiener (Rh-Hr) Terminology: Postulated a single gene locus producing an agglutinogen containing multiple blood factors. Uses R, r, primes, and double primes.

Understanding how to convert between these is a frequent requirement on MLT exams. The key conversions are based on standard rules:

• R indicates the presence of the D antigen.
• r indicates the absence of the D antigen.
• 1 or ' (prime) indicates the presence of C.
• 2 or '' (double prime) indicates the presence of E.
• 0 (zero) or nothing indicates the presence of c and e.
• z or y indicates the presence of both C and E.

Common Conversions:

• $R_0$ = Dce
• $R_1$ = DCe
• $R_2$ = DcE
• $R_z$ = DCE
• $r$ = dce
• $r'$ = dCe
• $r''$ = dcE
• $r^y$ = dCE

Weak D Testing

The D antigen is the most immunogenic Rh antigen. Individuals expressing the D antigen are typed as "Rh positive." Some individuals have weakened expression of the D antigen not detectable by direct agglutination at room temperature. This requires an indirect antiglobulin test (IAT) to demonstrate the antigen's presence, termed "Weak D." Causes include Genetic Weak D (fewer D antigen sites), Position Effect (C in trans to D, causing steric hindrance), and Partial D (missing one or more D epitopes). Weak D testing is crucial for blood donors, as Weak D positive red cells can immunize a true Rh-negative recipient.

Other Clinically Significant Blood Group Systems

Beyond ABO and Rh, several other carbohydrate-based blood group systems possess unique clinical correlations that are vital to understand.

The Lewis System

The Lewis system is unique because Lewis antigens are not intrinsic to the red blood cell membrane. Instead, they are synthesized by tissue cells, secreted into body fluids (like plasma and saliva), and then subsequently adsorbed onto the red blood cell membrane from the plasma. The expression of Lewis antigens (Lea and Leb) depends entirely on the inheritance of the Lewis (Le) gene and the Secretor (Se) gene.

• Le(a+b-): The individual inherits the Le gene but lacks the Se gene (non-secretor). They produce Lea antigen, which adsorbs onto the RBCs. They do not produce Leb because the Se gene is required to add the specific fucose needed for Leb formation.
• Le(a-b+): The individual inherits both the Le gene and the Se gene (secretor). The presence of the Se gene enzyme converts almost all available Lea precursor into Leb. Therefore, the RBCs type as Leb positive. The small amount of remaining Lea is not enough to be detected on the red cells.
• Le(a-b-): The individual lacks the Le gene (lele). Regardless of their Secretor status, they cannot synthesize Lewis antigens, so neither Lea nor Leb will be found in their plasma or on their RBCs.

Lewis antibodies (anti-Lea and anti-Leb) are typically naturally occurring IgM antibodies that react optimally at room temperature. They are generally considered clinically insignificant because they rarely cause hemolytic transfusion reactions or Hemolytic Disease of the Fetus and Newborn (HDFN). This is because Lewis antibodies are IgM (cannot cross the placenta), and Lewis antigens often detach from transfused RBCs into the recipient's plasma, neutralizing the recipient's antibodies.

The I and i Antigens

The I and i antigens are carbohydrate structures related to the ABO and Lewis precursors. The expression of these antigens changes drastically with age.

• i antigen: Strongly expressed on fetal red blood cells and cord blood. At birth, almost all RBCs are i-positive and I-negative.
• I antigen: As the infant matures (typically by 18 months of age), the straight-chain i antigen is branched by a glycosyltransferase to form the complex I antigen. Therefore, adult red blood cells are strongly I-positive and i-negative.

Clinical Significance:

• Anti-I: A common, naturally occurring cold autoantibody (IgM) found in many adults. It typically reacts strongly at 4°C but not at body temperature, making it clinically insignificant most of the time. However, a potent, high-titer anti-I is the classic cause of Cold Agglutinin Disease (CAD), often triggered secondary to an infection with Mycoplasma pneumoniae. In the lab, strong anti-I can mask clinically significant alloantibodies, requiring techniques like prewarming or cold autoabsorption to resolve.
• Anti-i: A rare cold autoantibody. It is classically associated with infectious mononucleosis (Epstein-Barr virus infection).

The P Blood Group System

The P blood group system consists of structurally related antigens (P, P1, Pk) built on glycosphingolipid precursors. The most clinically notable phenotype is P1, which is found in about 80% of Caucasians.

• Anti-P1: A common, naturally occurring IgM cold agglutinin found in individuals with the P2 phenotype (who lack the P1 antigen). It is frequently neutralized using hydatid cyst fluid or pigeon egg white, which contain soluble P1-like substances, allowing blood bankers to rule out other underlying antibodies.
• Anti-P (Autoanti-P): An extremely significant biphasic IgG autoantibody that causes Paroxysmal Cold Hemoglobinuria (PCH), a rare autoimmune hemolytic anemia often seen in children following viral infections. The antibody binds to red cells in the cold peripheral circulation (e.g., in the extremities) and then fixes complement and causes severe intravascular hemolysis when the cells return to the warmer central circulation. It is diagnosed using the classic Donath-Landsteiner test.